First-in-man dose escalation and pharmacokinetic study of CAP7.1, a novel prodrug of etoposide, in adults with refractory solid tumours
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference20 articles.
1. Discovery of podophyllotoxins;Imbert;Biochimie,1998
2. Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses;Fan;DNA Repair (Amst),2008
3. Etoposide: discovery and medicinal chemistry;Meresse;Curr Med Chem,2004
4. Etoposide, topoisomerase II and cancer;Baldwin;Curr Med Chem Anticancer Agents,2005
5. Pharmacodynamics and long-term toxicity of etoposide;Kobayashi;Cancer Chemother Pharmacol,1994
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GuiErBai: a potent inhibitor, exhibiting broadly antitumor effect against cervical cancer in vitro and in vivo;Frontiers in Pharmacology;2024-06-10
2. The Biocatalysis in Cancer Therapy;ACS Catalysis;2023-05-25
3. Two-Photon Photodynamic Therapy Targeting Cancers with Low Carboxylesterase 2 Activity Guided by Ratiometric Fluorescence;Journal of Medicinal Chemistry;2022-06-14
4. Biosynthesis, total synthesis, and pharmacological activities of aryltetralin-type lignan podophyllotoxin and its derivatives;Natural Product Reports;2022
5. Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study;Cancers;2020-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3